Skip to content

Fish Oil Supplementation in Women With Gestational Diabetes

Effect of Fish Oil Supplementation in Women With Gestational Diabetes on Insulin Like Growth Factor-1 DNA Methylation in Newborns

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02371343
Enrollment
100
Registered
2015-02-25
Start date
2015-03-31
Completion date
2016-09-30
Last updated
2015-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Abnormality, Fetal Macrosomia, Other Respiratory Problems After Birth

Brief summary

Gestational diabetes is the development of diabetes during pregnancy. Left untreated, gestational diabetes and preeclampsia can lead to serious -- or even fatal -- complications for both mother and child. Some evidence suggesting omega-3 fatty acids might help protect women from two serious pregnancy complications -- gestational diabetes and preeclampsia. Omega-3 fatty acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her developing baby every advantage in life starting in-utero. Recent studies suggested that the biologic processes underlying the observed associations may involve epigenetic changes, specifically DNA methylation. In this study the investigators aimed to examine the effect of fish oil supplementation in women with gestational diabetes mellitus on newborn outcomes and insulin like growth factor 1 DNA methylation.

Detailed description

Gestational diabetes is the development of diabetes during pregnancy. According to the National Institutes of Health, gestational diabetes occurs in about 5 percent of all pregnancies in the United States, resulting in about 200,000 cases a year. Treatment involves dietary measures, exercise and, in some cases, insulin injections. All pregnant women should be taking a prescribed pre-natal vitamin, and should also supplement with fish oil or another source of omega-3 fatty acids to help support the nervous system of their developing child. Left untreated, gestational diabetes and preeclampsia can lead to serious -- or even fatal -- complications for both mother and child. In diabetic pregnancies there is an increased risk of birth defects. Some evidence suggesting omega-3 fatty acids might help protect women from two serious pregnancy complications -- gestational diabetes and preeclampsia. Omega-3 fatty acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her developing baby every advantage in life starting in-utero. In general the omega-3 fatty acids found in fish help the cardiovascular system, the brain (including moods), and even the brain and eyes of a developing baby. The risk of pre-term delivery and low birth weight is three and a half times higher when mothers are deficient in DHA. Recent studies suggested that the biologic processes underlying the observed associations may involve epigenetic changes, specifically DNA methylation. In this study the investigators aimed to examine the effect of fish oil supplementation in women with gestational diabetes mellitus on newborn outcomes and insulin like growth factor 1 DNA methylation.

Interventions

DIETARY_SUPPLEMENTFish oil, Ocean plus

Ocean Plus, 1200 mg, EPA 384 mg DHA 252 mg, total omega-3 782 mg, 50 soft gel, Ocean®, Germany

DIETARY_SUPPLEMENTSunflower Oil

Sponsors

Dr. Sami Ulus Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Women who were diagnosed as gestational diabetes mellitus (GDM) between 24 and 28th week of pregnancy * Women with GDM and accepted to be participate in the study * Women younger that 40 years old * The newborns of the women with GDM

Exclusion criteria

* The history of Type 1 diabetes melitus * Abnormal glucose tolerance \<20th gestational week * The history of chronic illness in the mother * Women who eat fish \<2 times in a week * Any history of sea-food allergy in the mother

Design outcomes

Primary

MeasureTime frameDescription
Birth size1 yearBirth size of the newborns

Secondary

MeasureTime frameDescription
Insulin like growth factor DNA methylation1 yearInsulin like growth factor DNA methylation

Countries

Turkey (Türkiye)

Contacts

Primary ContactDilek Dilli, Assoc Prof
dilekdilli2@yahoo.com+905422368250
Backup ContactNazan Doğan, MD
nazanneslihan@hotmail.com+903123055000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026